Isorem

Isosorbide dinitrate, the active ingredient in Isorem, is an organic nitrate presented as an oral tablet for systemic use. It acts as a vasodilator to relieve angina pectoris and to improve symptoms in patients with chronic heart failure, reducing cardiac workload and enhancing myocardial oxygen delivery in the coronary circulation. The drug is absorbed rapidly after ingestion and undergoes hepatic conversion to active metabolites that sustain nitric oxide release. GNH USA supplies Isorem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isosorbide dinitrate is used in the management of cardiovascular conditions that involve reduced myocardial oxygen supply. - Angina pectoris: provides rapid relief of chest pain by dilating coronary vessels and decreasing cardiac workload. - Chronic heart failure: reduces preload and afterload, improving exercise tolerance and symptoms. - Prophylaxis of angina attacks: maintains vasodilation to prevent episodes of chest discomfort. - Ischemic heart disease: enhances myocardial oxygen delivery and reduces ischemic episodes.

Isosorbide dinitrate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: throbbing pain often occurring shortly after dosing. - Dizziness or light‑headedness: due to blood pressure lowering. - Flushing: warm sensation and reddening of the skin. - Hypotension: noticeable drop in blood pressure, sometimes with faintness. - Tachycardia: compensatory increase in heart rate. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure leading to shock. - Syncope: sudden loss of consciousness. - Myocardial infarction: rare occurrence of heart attack. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Methemoglobinemia: rare blood disorder causing reduced oxygen delivery.

When prescribing isosorbide dinitrate, several safety considerations should be observed. - Dose titration: start with low dose and increase gradually to minimize hypotension. - Avoid concurrent use of phosphodiesterase‑5 inhibitors: risk of severe hypotension. - Monitor blood pressure: check regularly especially after dose changes. - Use with caution in patients with anemia or severe aortic stenosis. - Pregnancy and lactation: safety not established; weigh benefits vs risks. - Store at ambient temperature: keep below 25°C, protect from moisture and light.

Isosorbide dinitrate can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause profound hypotension. - Concurrent use of other organic nitrates: additive vasodilatory effect leading to severe blood pressure drop.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (ACE inhibitors, beta‑blockers): may enhance blood pressure‑lowering effect. - Diuretics: can increase risk of hypotension, especially with high doses. - Alcohol: may potentiate vasodilatory effects and dizziness.